Array BioPharma 3200 Walnut Street Boulder, CO 80301 Phone: 303.381.6600 Site Map | Privacy Policy | Legal Copyright © 2014 Array BioPharma All Rights Reserved Welcome to Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, ARRY-520, for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis). Latest News and Press Releases: 2/18/2014 Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences 2/6/2014 Array BioPharma To Present At The Leerink Swann Global Healthcare Conference 2/4/2014 Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014 1/29/2014 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014 Quick Links: About Array Management Team Board of Directors Product Pipeline Cancer Inflammation and Pain Array Science Product Pipeline Patents & Publications Array Discovery Platform Collaborating with Array Existing Partners Integerated Drug Discovery Services Available Preclinical Programs Patents & Publications Publications Patents Posters & Presentations Investor Relations News Events & Webcasts SEC Filings & Reports Stock Info Analyst Coverage Fundamentals Earnings Estimates FAQs Information Request Financial Tearsheet Corporate Governance Careers Current Job Openings Employee Benefits Working at Array Colorado Lifestyle Contact Info Directions & Maps Email this page Printer friendly version About Array Product Pipeline Array Science Collaborating with Array Patents & Publications Investor Relations Careers Contact Info